Impact of GTV-CTV margin and other predictors on radiation-induced dysphagia in head and neck cancer patients from DAHANCA group
Authors:
- Sarah Wordenskjold StougaardSSSarah Wordenskjold Stougaard
- Ruta ZukauskaiteRZRuta Zukauskaite
- Ebbe Laugaard LorenzenELEbbe Laugaard Lorenzen
- Simon Long KroghSKSimon Long Krogh
- Camilla Panduro NielsenCNCamilla Panduro Nielsen
- Jørgen JohansenJJJørgen Johansen
- Jesper Grau EriksenJEJesper Grau Eriksen
- Camilla Kjaer LonkvistCLCamilla Kjaer Lonkvist
- Jeppe FriborgJFJeppe Friborg
Open Access
- 18 September 2025
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 1253-1261
Abstract
Background and purpose: This multicentre, retrospective study aimed to develop a predictive model for radiation-induced dysphagia in head and neck cancer patients, focusing on the role of gross tumour volume (GTV) to high dose CTV (CTV1) margin size and dose-related factors. Unlike previous studies focused on peak or single time-point dysphagia, this study modelled symptom trajectories using repeated follow-up data for a more complete picture. Patient/material and methods: Between 2010 and 2015, 1,948 patients with pharyngeal or laryngeal squamous cell carcinoma received definitive intensity-modulated radiotherapy (IMRT) at three Danish centres. Data included physician-rated dysphagia (grade 0–4), tumour and treatment characteristics, and AI-based segmentations of organs at risk (OARs). Predictors included GTV-CTV1 margin size, mean doses to the oral cavity and pharyngeal constrictor muscles (PCM), GTV volume, chemotherapy, tumour site, fractionation, nimorazole, sex, smoking status, baseline dysphagia, and age. A logistic ordinal mixed-effects model was fitted with patient ID as random effect. Data were split into training (70%) and test (30%) sets. Model performance was assessed using calibration plots and area under the curve (AUC). Results: After excluding incomplete cases, 1,685 patients (7,829 visits) were analysed. GTV-CTV1 margin size was not significantly associated with dysphagia, although larger margins correlated with higher OAR doses. Higher doses to the lower PCM (odds ratio [OR] = 1.30 per 5 Gy) and oral cavity (OR = 1.32 per 5 Gy) increased risk. The model demonstrated good calibration and robust discrimination (AUC = 0.77–0.84). Interpretation: Radiation dose to the oral cavity and lower PCM were the strongest modifiable predictors of dysphagia risk. Margin size was not independently associated, possibly due to confounding by clinical judgement.Keywords
This publication has 26 references indexed in Scilit:
- Swallowing Function Outcomes in Head and Neck Cancer Survivors Followed by a Long‐Term Dysphagia Surveillance ProtocolHead & Neck, 2025
- Danish and Swedish National Data Collections for Cancer – Solutions for RadiotherapyClinical Oncology, 2024
- The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT)Radiotherapy and Oncology, 2019
- Patterns of failure, treatment outcomes and late toxicities of head and neck cancer in the current era of IMRTOral Oncology, 2018
- Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV marginsRadiotherapy and Oncology, 2018
- Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapyRadiotherapy and Oncology, 2018
- Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiationRadiotherapy and Oncology, 2015
- Late dysphagia after IMRT for head and neck cancer and correlation with dose–volume parametersRadiotherapy and Oncology, 2013
- Multilevel Statistical Models2010
- The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnairesRadiotherapy and Oncology, 2006